Search
for
Sort by
Research 31–60 of 1000+
- The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research
- Modulation of glucocorticoid action and the treatment of type-2 diabetes
- Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
- Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
- Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Chapter 7 Reproductive Dysfunction in Women with Epilepsy
- Cardiometabolic profile of young women with hypoprolactinemia
- Exercise activates the PI3K-AKT signal pathway by decreasing the expression of 5α-reductase type 1 in PCOS rats
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome
- Endocrinology of Hirsutism: From Androgens to Androgen Excess Disorders
- Low Starch/Low Dairy Diet Results in Successful Treatment of Obesity and Co- Morbidities Linked to Polycystic Ovary Syndrome (PCOS)
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Genetic ablation of myelin protein zero-like 3 in mice increases energy expenditure, improves glycemic control, and reduces hepatic lipid synthesis
- Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome
- Association between Polymorphisms of OCT1 and Metabolic Response to Metformin in Women with Polycystic Ovary Syndrome
- Premature adrenarche, polycystic ovary syndrome and intrauterine growth retardation: does a relationship exist?
- Subclinical hypothyroidism does not influence the metabolic and hormonal profile of women with PCOS
- Variations in alanine aminotransferase levels within the normal range predict metabolic and androgenic phenotypes in women of reproductive age
- How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
- Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: a systematic review
- Effects of Exercise Combined with Finasteride on Hormone and Ovarian Function in Polycystic Ovary Syndrome Rats
- Interval training and cardiometabolic health in reproductive-aged females
- Cardiometabolic Risk Factors in Atorvastatin-Treated Women with Euthyroid Autoimmune Thyroiditis
- Cross-sectional study of the association between skin tags and vascular risk factors in a bariatric clinic-based cohort of Irish adults with morbid obesity
- The Possibilities of Using Chromium Salts as an Agent Supporting Treatment of Polycystic Ovary Syndrome
- Metformin or thiazolidinedione therapy in PCOS?
- GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity